The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Peroxisome proliferator‐activated receptor‐γ agonists prevent experimental autoimmune encephalomyelitis
Abstract
The development of clinical symptoms in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE) involves T‐cell activation and migration into the central nervous system, production of glial‐derived inflammatory molecules, and demyelination and axonal damage. Ligands of the peroxisome proliferator‐activated receptor (PPAR) exert anti‐inflammatory effects on glial cells, reduce proliferation and activation of T cells, and induce myelin gene expression. We demonstrate in two models of EAE that orally administered PPARγ ligand pioglitazone reduced the incidence and severity of monophasic, chronic disease in C57BL/6 mice immunized with myelin oligodendrocyte glycoprotein peptide and of relapsing disease in B10.Pl mice immunized with myelin basic protein. Pioglitazone also reduced clinical signs when it was provided after disease onset. Clinical symptoms were reduced by two other PPARγ agonists, suggesting a role for PPARγ activation in protective effects. The suppression of clinical signs was paralleled by decreased lymphocyte infiltration, lessened demyelination, reduced chemokine and cytokine expression, and increased inhibitor of kappa B (IkB) expression in the brain. Pioglitazone also reduced the antigen‐dependent interferon‐γ production from EAE‐derived T cells. These results suggest that orally administered PPARγ agonists could provide therapeutic benefit in demyelinating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Subbaramaiah, K., Lin, D. T., Hart, J. C., & Dannenberg, A. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007237200 · Cited by 275
RetractedLehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 4×
“E-mail: dlfeins@uic.edu 694 © 2002 Wiley-Liss, Inc. such as troglitazone, pioglitazone (PIO), and rosiglitazone,15 and tyrosine-based agonists such as GW347845.”
BackgroundInfluentialRegulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 712
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Self-citationClark, R. B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., & Padula, S. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1364 · Cited by 465
Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.827 · Cited by 457
Gervois, P., Fruchart, J.-C., Delerive, P., & Staels, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004045200 · Cited by 456
Yang, X. Y., Wang, L. H., Chen, T., Hodge, D. R., Resau, J. H., DaSilva, L., & Farrar, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4541 · Cited by 377
Ricote, M., Huang, J. T., Welch, J. S., & Glass, C. K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.733 · Cited by 304
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Diab, A., Deng, C., Smith, J. D., Hussain, R. Z., Phanavanh, B., Lovett-Racke, A. E., Drew, P. D., & Racke, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2508 · Cited by 291
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
Bernard, C. C. A., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J., & Bettadapura, J. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050092 · Cited by 270
Heneka, M. T., Klockgether, T., & Feinstein, D. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06862.2000 · Cited by 269
Self-citationColville-Nash, P. R., Qureshi, S. S., Willis, D., & Willoughby, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.978 · Cited by 241
Bernardo, A., Levi, G., & Minghetti, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00110.x · Cited by 222
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L. J., Kadowaki, T., Blumberg, R. S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.21191 · Cited by 216
Ellis, C. N., Varani, J., Fisher, G. J., Zeigler, M. E., Pershadsingh, H. A., Benson, S. C., Chi, Y., & Kurtz, T. W. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.5.609 · Cited by 212
Self-citationPPAR ? agonists stimulate oligodendrocyte differentiation in tissue culture
Saluja, I., Granneman, J. G., & Skoff, R. P. (2001) · Glia · doi:10.1002/1098-1136(200103)33:3<191::aid-glia1018>3.0.co;2-m · Cited by 200
Harris, S. G., & Phipps, R. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1098::aid-immu1098>3.0.co;2-i · Cited by 195
Niino, M., Iwabuchi, K., Kikuchi, S., Ato, M., Morohashi, T., Ogata, A., Tashiro, K., & Onoé, K. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00285-5 · Cited by 188
Han, K. H., Chang, M. K., Boullier, A., Green, S. R., Li, A., Glass, C. K., & Quehenberger, O. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10052 · Cited by 168
Juedes, A. E., Hjelmström, P., Bergman, C. M., Neild, A. L., & Ruddle, N. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.419 · Cited by 161
(1997) · PubMed · Cited by 139
Maggi, L. B., Sadeghi, H., Weigand, C. M., Scarim, A. L., Heitmeier, M. R., & Corbett, J. A. (2000) · Diabetes · doi:10.2337/diabetes.49.3.346 · Cited by 130
Chattopadhyay, N., Singh, D. P., Heese, O., Godbole, M. M., Shinohara, T., Black, P. M., & Brown, E. M. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000701)61:1<67::aid-jnr8>3.0.co;2-7 · Cited by 109
Immunologic Therapy of Multiple Sclerosis
Arnason, B. G. W. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.291 · Cited by 73
Benson, J., Stuckman, S. S., Cox, K. L., Wardrop, R. M., Gienapp, I. E., Cross, A. H., Trotter, J. L., & Whitacre, C. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6247 · Cited by 70
Self-citationTreatment of multiple sclerosis: recent trials and future perspectives
Noseworthy, J. H., Gold, R., & Hartung, H. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199906000-00007 · Cited by 66
Kanwar, J. R., Kanwar, R. K., Wang, D., & Krissansen, G. W. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00947.x · Cited by 63
Evaluation of mitoxantrone for the treatment of multiple sclerosis
Jain, K. K. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.5.1139 · Cited by 44
Emerson, M. R., Biswas, S., & LeVine, S. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00394-0 · Cited by 38
Abbas, N., Zou, L., Pelidou, S., Winblad, B. G., & Jiezhu, Z. (2000) · Autoimmunity · doi:10.3109/08916930008994078 · Cited by 33
Selmaj, K. W. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i94 · Cited by 29
Cytokine‐directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis
Ruuls, S. R., & Sedgwick, J. D. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00715.x · Cited by 20
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Cited by
Fat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Self-citationRisner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Moreno, S., Farioli-Vecchioli, S., & Cerù, M. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.064 · Cited by 587
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574
Metadata
- Authors
- Feinstein, D. L., Galea, E., Gavrilyuk, V., Brosnan, C. F., Whitacre, C. C., Dumitrescu‐Ozimek, L., Landreth, G. E., Pershadsingh, H. A., Weinberg, G., & Heneka, M. T.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2002-05-21
- Volume
- 51
- Issue
- 6
- Pages
- 694-702
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2144473903
- Cited by
- 294
- References
- 42
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.